Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03217968 · ClinicalTrials.gov registry record · NA

Abortive Treatment of Migraine With the Cefaly® Abortive Program Device

A NA study of Migraine, sponsored by Cefaly Technology.

Completed
Registry status
NA
Development phase
59
Enrollment target
1
Study location

NCT03217968 is a NA study of Migraine that has completed, run by Cefaly Technology. The registered enrollment target is 59 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03217968, a NA study of Migraine, has completed, sponsored by Cefaly Technology.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the efficacy of the Cefaly® Abortive Program device used at home for 2 hours to treat a migraine attack. This open clinical trial will study the abortive treatment of migraine using the Cefaly® Abortive Program device, prior to development of a sham-controlled trial.

Conditions Studied

Migraine

Interventions

  • DEVICE Cefaly® Abortive Program device

Study Locations (1)

New York

  • Rochester Clinical Research, Inc. - Rochester

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2017-08-10
Est. Completion 2018-01-10
Phase NA

Sponsor

Cefaly Technology

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03217968

The ClinicalTrials.gov registry entry for NCT03217968 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (84% lower). The listed sponsor is Cefaly Technology, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which Cefaly® Abortive Program device is the first listed.

NCT03217968 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03217968 about?

NCT03217968 is a clinical study titled "Abortive Treatment of Migraine With the Cefaly® Abortive Program Device". The purpose of this study is to investigate the efficacy of the Cefaly® Abortive Program device used at home for 2 hours to treat a migraine attack. This open clinical trial will study the abortive treatment of migraine using the Cefaly® Abortive Program device, prior to development of a sham-contro...

What is the current status of trial NCT03217968?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2017-08-10. Estimated completion is 2018-01-10.

What conditions does trial NCT03217968 study?

This clinical trial studies the following conditions: Migraine.

What interventions are being tested in trial NCT03217968?

The interventions under investigation include: Cefaly® Abortive Program device (DEVICE).

Who is sponsoring clinical trial NCT03217968?

This trial is sponsored by Cefaly Technology, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03217968 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Migraine

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.